GLP-1s Should Be First Step to Stop Heart Disease, ACC Says (2)

Millions more Americans should be taking weight-loss drugs to prevent heart disease, according to the American College of Cardiology.

Exercise and a clean diet aren’t always enough for heart health, the nation’s top cardiology organization said in new recommendations released on Friday. Weight-loss drugs should be used earlier, making them part of the first line of defense for obese patients, the group said.

Novo Nordisk A/S’s Wegovy and Eli Lilly & Co.’s Zepbound should be considered when choosing primary treatments to avert heart disease, the leading cause of death in the US, according to the new guidelines. The ...